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Background: The great potential of plants as Hymenaea courbaril L (jatoba) has not yet been throughly explored
scientifically and therefore it is very important to investigate their pharmacological and toxicological activities to
establish their real efficacy and safety. This study investigated the cytotoxicity of xylem sap of Hymenaea courbaril L
and its bioactivity against the fungi Cryptococcus neoformans species complex and dermatophytes.
Methods: The fresh xylem sap of H. courbaril was filtered resulting in an insoluble brown color precipitate and was
identified as fisetin. In the filtrate was identified the mixture of fisetinediol, fustin, 3-O-methyl-2,3-trans-fustin and
taxifolin, which were evaluated by broth microdilution antifungal susceptibility testing against C. neoformans species
complex and dermatophytes. The fresh xylem sap and fisetin were screened for cytotoxicity against the 3T3-A31
cells of Balb/c using neutral red uptake (NRU) assay.
Results: The fresh xylem sap and the fisetin showed higher in vitro activity than the filtrate. The xylem sap of
H. courbaril inhibited the growth of dermatophytes and of C. neoformans with minimal inhibition concentration
(MIC) < 256 μg/mL, while the fisetin showed MIC < 128 μg/mL for these fungi. Fisetin showed lower toxicity
(IC50 = 158 μg/mL) than the fresh xylem sap (IC50 = 109 μg/mL).
Conclusion: Naturally occurring fisetin can provide excellent starting points for clinical application and can certainly
represent a therapeutic potential against fungal infections, because it showed in vitro antifungal activity and low
toxicity on animal cells.
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Covering about a quarter of Brazil, the cerrado is the
nation’s second largest biome after the Amazon and it
is characterized by different vegetation physiognomies,
comprising savanna-like formations, forest forms, and
also gallery forests [1,2]. The endemic plants are adapted
to drought and fire, and this may be responsible for the
large diversity in their secondary metabolites. In central
Brazil, a substantial part of the population relies on medi-
cinal plants for primary health care. The great potential of* Correspondence: rosario@ufg.br
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unless otherwise stated.these plants has not yet been thoroughly explored scientif-
ically and therefore it is very important to investigate the
pharmacological and toxicological activity of these herbs to
establish their real efficacy and safety. From our screening
program, we selected Hymenaea courbaril L. (Fabaceae) a
medicinal species popularly known in Brazil as ‘jatoba’
which has a long history of use as medicinal plant by indi-
genous tribes of the Amazon Basin and also in caatinga
and cerrado communities. The jatoba bark is used to give
energy and stamina, as well as a tonic for the respiratory
tract and for the treatment of urinary systems. The fruit is
used to treat mouth ulcers, and the leaves and wood are
used for diabetes. The “jatoba” is also used popularly foral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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ach problems as well as to treat mycoses of nails [3].
Scientific studies on the medicinal properties of H.
courbaril revealed antimicrobial activity against Gram-
positive bacteria and dengue virus type-2 [4,5]. The sec-
ondary metabolites of this plant showed the presence of
flavonoid fisetin as the major compound [6], probably
responsible for the antimicrobial properties. Fisetin is a
natural flavonoid of interest in cancer prevention and
therapy because this compound is relatively non toxic
compared to other chemotherapeutic agents used in
cancer therapy [7-9]. Fisetin possesses antioxidant and
anti-inflammatory activity and was found to be cytotoxic
and antiangiogenic in vitro [10-12]. After systemic admin-
istration in mice, fisetin has shown interesting antitumor
activity in several cancer models, including prostate,
teratocarcinoma and lung carcinoma [12,13]. According
to Touil et al. [12] fisetin was found to be several times
less cytotoxic towards normal NIH 3T3 cells when com-
pared to tumor cells, and this could give to this compound
an important in vivo advantage in terms of therapeutic
index.
The fungal infections represent a significant problem to
health and are one of the causes of morbidity and mortal-
ity in the world. The dermatophytosis caused by filament-
ous fungi such as Microsporum spp,Trichophyton spp and
Epidermophyton floccosum represents a serious medical
problem affecting about 20-25% of the world’s population
[14]. This mycosis affects mainly human scalp, feet and
hands, nails and interdigital areas involving the patient’s
life quality [15]. The cryptococcosis caused by yeasts of C.
neoformans species complex is an opportunistic infection
that frequently causes meningoencephalitis in patients with
impaired immune systems [16-19]. In Brazil, cryptococ-
cosis is diagnosed in course at the time of disease in about
6% of acquired immune deficiency syndrome (AIDS) pa-
tients [20,21]. According to the Center for Disease Control
Prevention (CDC) cryptococcal meningitis kills about
624,000 people each year [19]. Drugs used for treatment of
cryptococcosis and dermatophytosis have considerable
side-effects and adverse effects accompanied by the
development of resistance by microorganism with reduced
ability to clear completely the infection [22-25].
Some reports have described the biological activities of
leaves, seed and trunk resin of H. courbaril [26-29], but
there is a lack of information on the xylem sap. In the
present work, we have focused on the phytochemical study,
cytotoxicity and antifungal activity of the fresh xylem sap
of H. courbaril and its major compound fisetin (1).
Methods
Extraction and isolation
The fresh xylem sap (extracted from hole through the bark
to heartwood from jatoba tree, 250 mL), of H. courbarilwas purchased in “Vaga-Fogo” Farm, Pirenopolis, Goiás,
Brazil. The insoluble brown color precipitate was filtered
through filter paper and it was analyzed by 1H and 13C
NMR [Varian Mercury plus BB spectrometer, operating at
300.059 MHz (1H) and 75.458 MHz (13C) using CDCl3
solutions with TMS as an internal standard] and was
identified as fisetin (1, 10 mg).
The filtrate of fresh xylem sap was lyophilized, and the
dried extract (2.6 g) was fractionated on silica gel 60 using
a hexane/ethyl acetate mixture of increasing polarity to
yield 30 mg of the mixture of 4 compounds wich were
eluted with hexane/ethyl acetate (20:80) and it were iden-
tified by the 1D and 2D NMR analysis. Fisetinediol (2);
fustin (3); 3-O-methyl-2,3-trans-fustin (4) and taxifolin (5)
were identified in the mixture. The NMR data were com-
pared to literature (Mujwah et al. [30], Piacente et al. [31]
and Baderschneider & Winterhalter [32]).
Structural elucidation
Fisetin (1)
1H NMR (300 MHz, MeOD) 6.88 (d; 8.1, H5′); 6.91 (d;
2.1, H8); 6.92 (dd; 8.7; 2.1, H6); 7.66 (dd; 8.1; 2.1, H6′);
7.76 (d; 2.1, H2′); 7.98 (d; 8.7, H5); 13C NMR (75 MHz,
MeOD): 103.0 (C8); 115.4 (C10); 115.9 (C2′); 116.0 (C5′
and C6); 121.6 (C6′); *124.2 (C1′); *127.6 (C5); 138.6
(C3); *147.1 (C2, C3′and 4′); 158.5 (C9); *164.0 (C7);
173.4 (C4).
The profile in HPLC of crude extract was carried on a
Shim-Pack CLC-ODS (H) (4.6 mm × 25 cm) was per-
formed on a Shimadzu LC8A system, using 30% meta-
nol/H2O acidified with 0.3% formic acid as eluent. The
Figure 1 shows a comparison of fisetin (1) and crude
extract sap.
Fisetinediol (2)
1H NMR (300 MHz, MeOD) 2.67 (dd; 15,9; 7,8; H4a);
2.87 (dd; 15.9; 5.1; H4b); 3.99 (ddd; 7.8; 7.2; 5.1; H3); 4.63
(d; 7.2; H2); 6.27 (d; 2.4; H8); 6.33 (dd; 8.1; 2.4, H6); 6.69
(dd, 8.1; 2.1; H6′); 6.75 (d; 8.1; H5′); 6.81 (d; 2.1; H2′);
6.85 (d; 8.1;H5). 13C NMR (75 MHz, MeOD): 33.1 (C4);
83.0 (C2); 68.8 (C3); 103.6 (C8); 109.4 (C6); 112.5 (C10);
115.1 (C2′); 116.1 (C5′); 119.8 (C6′); 131.3 (C5); 132.2
(C1′); 146.3 (C3′);146.3 (C4′);156.2 (C9); 157.9 (C7);
Fustin (3)
1H NMR (300 MHz, MeOD) 4.47 (d; 11.7, H3); 4.92#
(H2); 6.26 (d; 2.1, H8); 6.35 (dd; 8.9; 2.1, H6); 6.83
(m, H6′); 6.89 (d; 8.4, H5′); 6.97 (d; 2.1, H2′); 7.67
(d; 8.9, H5); 13C NMR (75 MHz, MeOD): 74.6 (C3);
85.5 (C2); 103.8 (C8); 109.3 (C6); *114.0 (C10); 115.9
(C2′);116.2 (C5′);120.9 (C6′);*129.9 (C1′);133.5(C5);
*146.2 (C3′);*147.1 (C4′);*166.9 (C9);*167.0 (C7);
*205.0 (C4).
Figure 1 Chemical structures of the compounds 1-5.
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1H NMR (300 MHz, MeOD) 3.30# (OCH3); 4.16 (d; 10.2,
H3); 5.06 (d; 10.2, H2); 6.32 (d; 2.1, H8); 6.51 (dd; 8.7; 2.1,
H6); 6.79 (d; 8.1, H5’); 6.83 (m, H6’); 6.93 (d; 2.1, H2’);
7.69 (d; 8.7, H5); 13C NMR (75 MHz, MeOD): 60.6
(OCH3); 83.4 (C3); 84.2 (C2); 103.7 (C8); 112.2 (C6);
*113.8 (C10);115.6 (C2′);116.0 (C5′); 120.4 (C6′);*129.9
(C1′); 130.1 (C5); *146.3 (C3′);*147.1 (C4′);*166.9 (C9);
*167.0 (C7); *205.0 (C4).
Taxifolin (5)
1H NMR (300 MHz, MeOD) 4.49 (d; 11.4, H3); 4.89#
(H2); 5.87 (d; 2.1; H8); 5.91 (d; 2.1; H6); 6.79 (d; 8.1,
H5′); 6.83 (m, H6′); 6.95 (d; 2.1, H2′). 13C NMR (75
MHz, MeOD): 73.7 (C3);85.1 (C2); 97.4 (C6); 96.4 (C8);
101.9 (C10); 115.8 (C2′);116.0 (C5′);120.9 (C6′);129.9
(C1′);147.1 (C3′ and C4′); 164.0 (C9); *166.8 (C5);
*169.0 (C7).
*The signal could be exchanged. #These signals were
under the solvent signal, then were attributed by HSQC
experiment.
Fungal strains
The microorganisms used in this study were obtained
from the fungal collection of the Laboratory of Mycology
(IPTSP - UFG), from previously work performed in
Goiânia-GO at the ‘Hospital das Clínicas’ (HC-UFG)
and the ‘Hospital de Doenças Tropicais’ approved by the
respective hospitals ethics committees with protocols
numbers 007/2004 and 065/2008. These microorganisms
comprised 18 strains of dermatophytes and 26 of C. neo-
formans species complex. The fungi were maintained on
Sabouraud dextrose agar at -70°C (Difco) and subcultured
on the same medium for 72 hours before testing.
In vitro susceptibility testing
The in vitro activity of the sap of H. courbaril and the
isolated compounds and mixture was evaluated using
the broth microdilution method, as described in Clinical
and Laboratory Standards Institute (CLSI) documents
M27-A3 for yeasts and M38-A2 (with some modifica-
tions) for dermatophytes [33-35].
In a previous experiment, xylem sap and the com-
pounds 1-5 were screened broth microdilution methodagainst six isolates of dermatophytes and six of yeasts of
C. neoformans species complex, with concentrations ran-
ging from 256 to 0.25 μg/mL for both fungi. Posteriorly,
according to results obtained, in vitro susceptibility tests
were also performed using fresh xylem sap and fisetin
against 18 dermatophytes and 26 yeasts, with concentra-
tions ranging from 256 to 0.25 μg/mL for fresh xylem
sap and from 128 to 0.125 μg/mL for fisetin.
Cell suspensions of C. neoformans were prepared from
3-day-old cultures in Sabouraud’s dextrose agar at 28°C in
sterile saline (0.85%), and the optical density was adjusted
using a spectrophotometer to 85% transmittance at a wave-
length of 530 nm. This suspension was diluted to 1:50 and
then 1:20 in RPMI 1640 medium (Sigma Chemical Co., St.
Louis, MO, USA) buffered to a pH of 7.0 with 0.165 mol/L
MOPS (Sigma Chemical Co.) to obtain a final inoculum of
approximately 1 to 5×103 CFU⁄mL [33].
The inocula of dermatophytes were performed accord-
ing to Santos et al. [35]. Briefly, the isolates were subcul-
tured in potato dextrose agar at 28°C for 7 days to
produce conidia. The fungal colonies were then covered
with 5 mL of sterile saline (0.85%), and suspensions were
made by scraping the surface with the tip of a Pasteur
pipette. The resulting conidia and hyphal particles were
transferred to a sterile tube and allowed to settle for
15–20 min at room temperature. The density of the
suspension was adjusted using a spectrophotometer at
wavelength of 520 nm to a transmittance of 70 to
72%. The resulting suspension was diluted to 1:50 in
RPMI medium to obtain the final inoculum of approxi-
mately 2 to 4×104 CFU⁄mL [34].
The MIC values were determined after 5 days of incu-
bation at 28°C for dermatophytes and after 72 h at 37°C
for yeasts. The MIC was defined as the lowest concen-
tration showing 100% growth inhibition compared with
growth in the control. Candida parapsilosis ATCC 22019
and C. neoformans ATCC 28957 were used as controls.
Itraconazole (Sigma Chemical Co.) and DMSO diluted in
the same way were included as quality controls. Each
experiment was performed in duplicate.
In vitro Cytotoxicity
Cell viability was evaluated by neutral red uptake (NRU)
according to Borenfreund and Puerner [36], modified by
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blast cell line was grown in DMEM-1640 [(Sigma™, St
Louis, MO), high glucose medium containing 10% FBS
(Cultilab™)]. The cells were harvested with trypsin/EDTA
and seeded (100 μL/well) at an initial density of 3×104
cells/mL into a 96-well plate and incubated overnight.
After 24 hours of incubation at 37°C, the cells were treated
with eight different concentrations (256 to 2 μg/mL) of
fresh xylem sap or fisetin diluted in DMEM medium and
incubated for 48 h. The medium was aspirated and re-
placed with 250 μL per well (including blank) of neutral
red (NR) solution. After 3 h incubation (37 ± 1ºC, 90 ± 10%
humidity, 5 ± 1% CO2/air) the NR medium was removed,
and the cells were washed with pre-warmed PBS. The PBS
was decanted and 100 μL of an aqueous solution of 1%
acetic acid: 50% ethanol (v/v) was added to each well to
extract the dye. After rapid shaking (20 min) in a microtitre
plate shaker, the absorbance was read at wavelength
of 540 nm.
Cytotoxicity tests were performed at least three times,
using six wells for each concentration of fresh xylem sap
or of fisetin. The data for the dose-response cytotoxicity
curves are presented as the arithmetic mean and standard
deviation. Linear regression analysis was used to compute
the concentration that reduced absorbance by 50% (IC50).
The NRU assay results are expressed as the percentage
uptake of neutral red dye by lysosomes.
Results
The screening of in vitro antifungal susceptibility of fresh
xylem sap, fisetin (1) and the mixture of fisinetidiol (2),
fustin (3), 3-O methyl, 2,3-trans-fustin (4) and taxifolin
(5) (Figure 1) of H. courbaryl showed that both yeasts
(6 strains) and dermatophytes (6 strains) were more
susceptible to fresh xylem sap and to fisetin than the
mixture of compounds. In this screening, all the tested
strains showed susceptibility to fisetin at concentrations ofTable 1 In vitro antifungal activity of the sap and fisetin of H




M. gypseum (2) 64-128 128 128
T. mentagrophytes (8) 32-128 64 128
T. rubrum (7) 32-128 64 128
T. tonsurans (1) 128 128 128
Yeasts (n)
C. gattii (4) 128-256 128 256
C. neoformans (22) 8-256 64 256
MIC50 - inhibit the growth of 50% of isolates;
MIC90 - Minimal inhibitory concentration to inhibit the growth of 90% of isolates;
GM = Geometric Mean.32-128 μg/mL, while for xylem sap this concentration
ranged of 32-256 μg/mL.
In posterior evaluation against 44 isolates (18 dermato-
phytes and 26 yeasts), the fresh xylem sap of H. courbaril
inhibited the growth of dermatophytes and of C. neofor-
mans species complex with MIC values of 8-256 μg/mL
and geometric means of 64-181 μg/mL, while the fisetin
showed a MIC of 4-128 μg/mL and geometric means of
21.5-128 μg/mL for the fungi tested (Table 1). Quality
controls performed with itraconazole showed MIC of
1 μg/mL and of 0.25 μg/mL for all isolates of dermato-
phytes and C. neoformans species complex, respectively.
The results of in vitro cytotoxicity showed lower toxicity
of fisetin than of fresh xylem sap against 3T3-A31 cells of
Balb/c with an IC50 of 109 μg/mL for fresh xylem sap of
H. courbaril and of 158 μg/mL for fisetin. The percentage
of growth inhibition of the 3T3-A31 cells increased with
increasing concentrations of fresh xylem sap or fisetin as
shown in Figure 2. Reduction in the amount of fibroblast
cells 3T3-A31 treated with the fresh xylem sap and
fisetin visualized by inverted light microscope is showed
in Figure 3.
Discussion
Antifungal drugs available do not completely satisfy
the medical necessity due to problems such as spectrum,
potency, security, and their pharmacokinetic properties.
Nowadays, there is an increased interest in searching
for new antifungal compounds that function as select-
ive and low toxic. Natural products may be used as
templates for development of new drugs by the pharma-
ceutical industry and compounds extracted of plants have
been considered the major resources of bioactive agents.
It was estimated that at least 12000 active compounds
have been isolated from medicinal plants as anti-




GM Range MIC50 MIC90 GM
90.5 64-128 128 128 90.5
83 32-128 64 128 69.8
64 4-64 32 64 21.5
128 128 128 128 128
181 128 128 128 128
68,2 8-128 64 128 48.2
Figure 2 Cell viability of 3T3-A31 fibroblasts exposed to different concentrations of fresh xylem sap of H. courbaril (A) and of fisetin (B).
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activity of fisetin and fresh xylem sap from H. courbaril,
species largely found in Brazil, against yeasts of C. neo-
formans species complex and filamentous fungi as der-
matophytes. Numerous assay systems and organisms
have been used to screening plant extracts and constitu-
ents of active plants for antimicrobial activity. The broth
microdilution method used in this work has several ad-
vantages. This method is quantitative, allows the use of
small quantities of compounds or plant extracts as well
as culture media [40]. It was observed MIC values below
256 μg/mL for fisetin and for fresh xylem sap against
these fungi. There is no consensus in the literature on
the MIC values of a plant extract which qualifies it as
promising for fractionation. According to Kuete [40], the
antimicrobial activity of extracts can be classified as
follows: significant if MIC values are below100 μg/ml,
moderate when 100 <MIC < 625 μg/ml and weak if
MIC > 625 μg/ml. Therefore, the overall antifungal activ-
ity exhibited in this study varied from moderate to signifi-
cant. Previous studies have shown that flavonoids-rich
extracts possesses antimicrobial activity [41,42]. Although
the identification of mechanism action of flavonoids has
been discussed in the literature and there are indicationsA B
Figure 3 The cells of Balb/C untreated and treated with xylem sap an
treated with fresh xylem sap of H. courbaril at a concentration of 64 μg/mL
Photomicrograph at 200X by inverted microscope.that antimicrobial proprieties of flavonoids are due to its
interference with the specific intracellular of enzymes
surface [43-45], a new studies to the identification of
its mechanism action is still necessary.
In the present study, it was used NRU assay to deter-
mine the cytotoxic effect of fisetin and fresh xylem sap
of H. courbaril in Balb/c 3T3-A31 fibroblast cell line to
determine their IC50. Cell viability evaluation of fisetin
showed IC50 of 158 μg/mL and of sap of 109 μg/mL, with
low reduction of number of cells visualized by inverted
microscope (Figure 3). In this way, fisetin and xylem sap
had good results of IC50 when compared to their MIC
against Cryptococcus and dermatophytes. The xylem sap
of H. courbaril inhibited the growth of dermatophytes and
of the yeast C. neoformans species complex with MIC
below 256 μg/mL, while the fisetin showed MIC below
128 μg/mL. Cell cytotoxicity assays are commonly used
in vitro bioassay methods to predict the toxicity of sub-
stances in various tissues, because they demonstrate the
degree of damage caused by the chemical [46].
The results obtained in this work, showed lower toxic
effect of fisetin to mouse fibroblast cell line and higher
activity against fungi than fresh xylem sap of H. courbaril.
The naturally occurring flavonol, fisetin (C15H10O6), isC
d fisetin. A- The cell-fibroblast Balb/c 3T3-A31 untreated. B- Cells
. C- Cells treated with fisetin 1 at a concentration of 128 μg/mL.
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found in high concentrations in certain food plants, most
notably grape, onion and cucumber [47].
Conclusion
Thus, fisetin, has advantage over the antifungals used
commercially and can certainly represent a therapeutic
potential due to in vitro antifungal activity and low toxicity
on animal cells.
Although the results have suggested that fisetin may
be useful as antifungal drug, further studies of pharma-
cokinetics and pharmacodynamics aspects are needed
for utilization of this natural product.
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